Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-18-000008

Chief Executive Officer gave up 46,048 shares (to pay taxes)

  • Chief Executive Officer acquired 163,033 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kim Jong Joseph · Chief Executive Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2018-03-09 Exercise or conversion : show line 1 in the form +57,333 2,232,155 D
2018-03-09 Shares withheld for taxes : show line 2 in the form −15,944 $4.51 $71,907 2,216,211 D
2018-03-10 Exercise or conversion : show line 3 in the form +105,700 2,321,911 D
2018-03-10 Shares withheld for taxes : show line 4 in the form −30,104 $4.51 $135,769 2,291,807 D

Table II: Derivative

2 lines
Date Transaction Shares Underlying Owned after D/I
2018-03-09 Exercise or conversion : show line 5 in the form Restricted Stock Unit −57,334 57,333 57,333 D
2018-03-10 Exercise or conversion : show line 6 in the form Restricted Stock Unit −105,700 105,700 211,400 D
Loading xslF345X03/wf-form4_152098044956325.xml…